{Reference Type}: Case Reports
{Title}: Multimodal treatment of oligometastatic non-small cell lung cancer.
{Author}: Graça LL;Pego A;Lareiro S;Pancas R;
{Journal}: BMJ Case Rep
{Volume}: 16
{Issue}: 12
{Year}: 2023 Dec 7
暂无{DOI}: 10.1136/bcr-2023-256097
{Abstract}: The management of patients with oligometastatic non-small cell lung cancer has undergone significant improvement in recent years. The combination of increase in sensitivity of diagnostic tests, development in systemic therapies, surgical techniques and radiotherapy allowing radical ablative treatment of metastases have significantly influenced the treatment of advanced lung cancer, mainly in the patients in which these treatment modalities converge.We report a rare case of a young patient with an oligometastatic lung adenocarcinoma with a single synchronous brain metastasis, who underwent aggressive locoregional and systemic therapies and is still in annual follow-up with excellent quality of life and progression-free survival of 164 months.